Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The choice of antihypertensive therapy in the diabetic patient.

× No keyword cloud information.

47 in total

1. Hyperglycemia and glycosuria due to thiazide derivatives administered in diabetes mellitus.

Authors: M G GOLDNER; H ZAROWITZ; S AKGUN
Journal: N Engl J Med Date: 1960-02-25 Impact factor: 91.245

2. Effect of diltiazem on insulin secretion. I. Experiments in vitro.

Authors: I Yamaguchi; Y Akimoto; H Nakajima; A Kiyomoto
Journal: Jpn J Pharmacol Date: 1977-10

3. Effect of chronic administration of propranolol on lipoprotein composition.

Authors: N Tanaka; S Sakaguchi; K Oshige; T Niimura; T Kanehisa
Journal: Metabolism Date: 1976-10 Impact factor: 8.694

4. Beta-blockers and lipid metabolism.

Authors: H J Waal-Manning; F O Simpson
Journal: Br Med J Date: 1977-09-10

5. Stimulus-secretion coupling of glucose-induced insulin release. X. Effect of glucose on 45 Ca efflux from perifused islets.

Authors: W J Malaisse; G R Brisson; L E Baird
Journal: Am J Physiol Date: 1973-02

6. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.

Authors: A D Wright; S G Barber; M J Kendall; P H Poole
Journal: Br Med J Date: 1979-01-20

7. Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.

Authors: S P Deacon; A Karunanayake; D Barnett
Journal: Br Med J Date: 1977-11-12

8. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.

Authors: I Lager; G Blohmé; U Smith
Journal: Lancet Date: 1979-03-03 Impact factor: 79.321

9. Modification by propranolol of cardiovascular effects of induced hypoglycaemia.

Authors: R H Lloyd-Mostyn; S Oram
Journal: Lancet Date: 1975-05-31 Impact factor: 79.321

10. Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly.

Authors: A Amery; P Berthaux; C Bulpitt; M Deruyttere; A de Schaepdryver; C Dollery; R Fagard; F Forette; J Hellemans; P Lund-Johansen; A Mutsers; J Tuomilehto
Journal: Lancet Date: 1978-04-01 Impact factor: 79.321

5 in total

Review 1. Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors: F Dunne; M J Kendall; U Martin
Journal: Drugs Date: 2001 Impact factor: 9.546

2. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors: E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal: Br Med J (Clin Res Ed) Date: 1986-08-23

Review 3. Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes.

Authors: P Hamet; N Kalant; S A Ross; T W Wilson; F H Leenen; R B Haynes
Journal: CMAJ Date: 1988-12-01 Impact factor: 8.262

4. Ketanserin in the treatment of diabetes-associated hypertension.

Authors: C Beretta-Piccoli
Journal: Drugs Date: 1988 Impact factor: 9.546

Review 5. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors: D Faulds; E M Sorkin
Journal: Drugs Aging Date: 1992 Sep-Oct Impact factor: 3.923

5 in total